The company processes and distributes agricultural staples like spices, grains, and pulses, selling them under its own Shethji brand and through white-label manufacturing for other businesses.
The company operates in a highly commoditized industry with razor-thin net margins of 1.2%, indicating a lack of pricing power. While it is attempting to build a brand, the current financial profile reflects a volume-driven trading business rather than a protected consumer franchise.
Management recently utilized IPO proceeds to fund significant working capital expansion and solar infrastructure. While revenue growth is high, the business remains extremely capital-intensive with negative cash conversion, suggesting that growth requires constant external funding.
The business collapsed under the weight of its own growth as the negative cash conversion cycle forced a liquidity crisis. While revenue appeared to climb, the 62% surge in receivables compared to 18% revenue growth signaled that the company was essentially buying its sales by extending loose credit to customers. When commodity prices for chickpeas and coriander fluctuated, the razor-thin 1.2% margins evaporated into losses, and the heavy reliance on related-party transactions masked a fundamental inability to generate independent free cash flow, leading to a massive dilutive capital raise or insolvency.
RichFakir rates Shreeji Global FMCG Ltd's business quality as mediocre — 43/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shreeji Global FMCG Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shreeji Global FMCG Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shreeji Global FMCG Ltd's fair value is about ₹52 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →